The NEXTDC (ASX:NXT) share price is down 5% in a week. Is it a buy?

Is the NEXTDC share price in the buy zone now?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NEXTDC Ltd (ASX: NXT) share price is out of form on Tuesday.

In afternoon trade, the data centre operator's shares are down 1% to $13.30.

This means the NEXTDC share price is down 5% in the space of a week.

nextdc share price

Image source: Getty Images

Is the NEXTDC share price in the buy zone?

One top broker that believes the NEXTDC share price is good value is Goldman Sachs.

According to a recent note, the broker has a conviction buy rating and $14.40 price target on its shares.

Based on the latest NEXTDC share price, this implies potential upside of 8.3% over the next 12 months.

What did the broker say?

Goldman Sachs was pleased with the company's performance in FY 2021. And while NEXTDC's sales fell a touch short of the broker's forecasts, its earnings were ahead of expectations.

It commented: "NXT reported underlying FY21 Sales/EBITDA/NPAT that was -1.5%/+1.4%/+$1mn vs. GSe, with revenue at the lower end of guidance and EBITDA above the top end, with the revenue weakness attributable to lower zero margin power consumption of $4mn. 2H21 contracted MW of +4.5MW was in line with GSe +4.4MW. Cash conversion was strong, with capex of A$301mn well below GSe & guidance, attributable to covid delays."

The broker was also pleased with its guidance for FY 2022. NEXTDC is expecting revenue growth of 16% to 20% and EBITDA growth of 19% to 23%. Goldman notes that this was largely in line with its forecasts after adjusting for power pricing.

Looking further ahead, its analysts appear confident this strong form can continue, which supports the buy rating it has on the NEXTDC share price.

Goldman is forecasting an EBITDA compound annual growth rate (CAGR) of 20% through to FY 2024. At that point, the broker expects the company's EBITDA to have grown to $232 million. This compares very favourably to FY 2021's EBITDA of $133.9 million.

In light of this, the broker feels NEXTDC represents "the most compelling growth story in our coverage."

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »